DECEMBER 6–10, 2022

Henry B. Gonzalez Convention Center

|

San Antonio, TX



Check out the SABCS Virtual Exhibit Hall


The SABCS Virtual Exhibit Hall offers great opportunities to network and learn about the latest in products and services related to breast cancer research and treatment. The SABCS Virtual Exhibit Hall is open from 10:00 am to 3:00 pm CT each day of the Symposium.

Click here for the list of 2020 Virtual SABCS Exhibitors

In addition to their virtual booths, many exhibitors will also be offering educational opportunities via Product Theatre presentations and Satellite Events. Check the online schedule or SABCS mobile app for the most up-to-date program information.

PRODUCT THEATRES

Wednesday, December 9

10:00 am CT – Comprehensive Profiling of Early Stage Breast Cancer: A More Effective Path to Treatment presented by Agendia

12:00 pm CT – TUKYSA® (tucatinib): A Treatment Option for patients with HER2+ metastatic breast cancer (MBC) presented by Seattle Genetics

2:00 pm CT – Preventing Bone Complications in Patients with Solid Tumors Metastatic to Bone presented by Amgen

Thursday, December 10

10:00 am CT – A CDK 4 & 6 Inhibitor With Overall Survival Data for Women With HR+, HER2- Metastatic Breast Cancer, Including Those Likely To Do Worse presented by Lilly Oncology

12:00 pm CT – Yes or No? Answering chemotherapy and endocrine therapy questions through a case-based discussion with the Oncotype DX® testpresented by Exact Sciences (formerly Genomic Health)

2:00 pm CT – The evolving role of molecular biomarkers and therapies in breast cancer presented by Foundation Medicine

4:00 pm CT – Evidence supporting use of a Biosimilar in Cancer Treatment presented by Merck

Friday, December 11

12:00 pm CT – Selecting a First-in-Class Oral Therapy for Patients With HR+/HER2- Metastatic Breast Cancer presented by Pfizer

2:00 pm CT – Enhertu: Specifically Engineered ADC for HER2+ mBC
presented by Daiichi-Sankyo

4:00 pm CT – A Treatment Option for Patients With Certain Types of Advanced TNBC presented by Merck

OPEN SATELLITE EVENTS

Wednesday, December 9

7:30 pm CT – Navigating Treatment Options for HER2+ Breast Cancer Across the Disease Continuum: An Expert Tumor Board Discussion presented by Physicians’ Education Resource, LLC
Click here for more information and to register for this event.

Thursday, December 10

7:30 pm CT – Evolving Clinical Considerations for Breast Cancer Brain Metastases: Expert Case Discussionspresented by Clinical Care Options, LLC
Click here for more information and to register for this event.

7:30 pm CT – Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Patients with HER2-Positive Breast Cancer — Part 1 of a 2-Part CME Satellite Symposia Seriespresented by Research to Practice
Click here for more information and to register for this event.

Friday, December 11

7:30 pm CT – Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Patients with Triple-Negative Breast Cancer — Part 2 of a 2-Part CME Satellite Symposia Seriespresented by Research to Practice
Click here for more information and to register for this event.